Fox Rothschild LLP

Gerard P. Norton, Ph.D.

Partner

Patent Attorney

Princeton, NJ

609.844.3020

Send Email  Download vCard

body - Norton, Gerard

Co-chair of the firm’s Pharmaceutical & Biotechnology Group and a member of the Steering Committee of the Life Sciences Practice Group, Gerry has extensive experience litigating complex matters pertaining to patents, trademarks, copyrights, trade secrets and breach of contract. Gerry is also the former chair of the Intellectual Property Department.

He counsels clients regarding:

  • Validity and scope of intellectual property rights 
  • Portfolio development 
  • Strategic positioning of corporate assets, opinion work, and evaluating legal risk in the pharmaceutical and medical device industries 
  • Evaluating third-party intellectual property rights related to chemistry and molecular biology, such as therapeutic compounds, biopharmaceuticals, formulations, manufacture, importation, methods of use, and related FDA issues 
  • Representation of intellectual property matters and transactions relevant to corporate acquisitions and divestitures 

Gerry also provides skilled knowledge to manufacturers and developers in the fields of pharmaceutical, biotechnology, chemical and medical device arts.  

Gerry's clients include Fortune 100 companies as well as universities and other not-for-profit organizations.  

Representative Matters (Federal Circuit Appeals) 

  • Genentech, Inc. v. Novo Nordisk A/S, 108 F.3d 1361 (Fed. Cir. 1997); 
  • Bio-Technology Gen. Corp. v. Genentech, 80 F. 3d 1553 (Fed. Cir. 1996); 

 Representative Matters (District Litigation)  

  • Mr. Water Heater Enterprises, Inc. v 1-800-Hot Water Heater, LLC, 648 F. Supp. 2d 576 (S.D.N.Y., 2010); 
  • Fifth Generation Computer Corp. v. IBM, 678 F. Supp. 2d 184 (S.D.N.Y. 2010); 
  • Howmedica Osteonics Corp. v. Tranquil Prospects Ltd., WL 2750228 (N.D.I 2009); Howmedica Osteonics Corp. v. Tranquil Prospects Ltd., 482 F.Supp.2d 1045 (N.D.Ind.,2007); 
  • Precimed, S.A. v. Orthogenesis, Inc., 2006 WL 6160497, 2006 Markman 6160497 (E.D.PA. 2006); 
  • IMCOR Pharmaceutical Co. and Alliance Pharmaceutical Corp. v. Amersham Health, Inc., Amersham Health As and Amersham plc., 03-2853(SRC) (D.N.J. January 10, 2005); 
  • Greene, Tweed of Del., Inc. v. DuPont Dow Elastomers, L.L.C., 3002 U.S. Dist. LEXIS 21034 (E.D.P.A. 2003); 
  • Howmedica Osteonics Corp. v. Tranquil Prospects, LTD., 288 F. Supp. 2d. 939 (N.D.I. 2003); 
  • Greene, Tweed of Del., Inc. v. DuPont Dow Elastomers, L.L.C., 2003 U.S. Dist. LEXIS 15624 (E.D.P.A. 2003); 
  • Greene, Tweed of Del., Inc. v. DuPont Dow Elastomers, L.L.C., 2002 U.S. Dist. LEXIS 23554 (E.D.P.A. 2002); 
  • Greene, Tweed of Del., Inc. v. DuPont Dow Elastomers, L.L.C. 2002 U.S. Dist. LEXIS 25709 (E.D.P.A. 2002); 
  • Greene, Tweed of Del., Inc. v. DuPont Dow Elastomers, L.L.C., 2002 U.S. Dist. LEXIS 11389 (E.D.P.A. 2002); 
  • Greene, Tweed of Del., Inc.v. DuPont Dow Elastomers, L.L.C., 2002 U.S. Dist. LEXIS 11522 (E.D.P.A. 2002); 
  • Greene, Tweed of Del., Inc. v. DuPont Dow Elastomers, L.C.C., 202 F.R.D. 426 (E.D.P.A. 2001); 
  • Greene Tween of Del., Inc. v. DuPont Dow Elastomers, L.C.C., 202 F.R.D. 418 (E.D.P.A. 2001); 
  • Genentech, Inc, v. Boehringer Mannheim GmbH, 47 F. Supp. 2d91 (D. Mass 1999); 
  • Genentech, Inc. v. Boehringer Manheim GmbH, 989 F. Supp. 359 (D. Mass. 1997); 
  • Genentech, Inc. v. Novo Nordisk A/S, 935 F. Supp. 260 (S.D.N.Y. 1995). 

Before Fox Rothschild

Gerry was named partner of an intellectual property law firm in New Jersey, and was an attorney for 10 years at Rogers & Wells and at Clifford Chance in New York. He held a post-doctoral fellowship with Merck, Inc.

Client Resources

Technology is No. 1 Priority for U.S. Copyright Office
On October 25, 2011, the U.S. Copyright Office released a paper outlining 17 policy priorities for the next two years. In this podcast, Gerry discusses the highlights of the Office’s plans, including its intention to study and develop an alternative process for resolving small copyright infringement claims, conduct a preliminary analysis of the issues surrounding mass book digitization, and provide analysis and support to Congress in its effort to address a number of issues.
Listen to the Podcast

Honors and Awards

  • Selected as a "Life Sciences Star" for his outstanding patent work by LMG Life Sciences (2012, 2013)
  • Selected for inclusion in a list of “IP Stars” by Managing Intellectual Property (2012, 2013)

Practice Areas

Corporate
Intellectual Property
Litigation
Pharma & Biotech
Tech & Venture Finance
Life Sciences
Patent Prosecution & Transactions
Trademarks
IP Litigation
Trade Secrets
Post-Grant Proceedings
Antitrust
FDA Regulatory
Hatch-Waxman Patent Litigation
International Trade Commission Litigation
International
Bar Admissions

New Jersey

New York


Education

J.D., Fordham University School of Law

Ph.D. in Microbiology, Virology and Immunology, Mount Sinai School of Medicine

B.A., Fordham College, Biology


Court Admissions

U.S. Supreme Court

U.S. Court of Appeals, Federal Circuit

U.S. Patent & Trademark Office

U.S. District Court, Northern District of Indiana

New Jersey state and federal courts

New York state and federal courts


Memberships

American Bar Association

American Association for Justice

American Intellectual Property Law Association

New Jersey State Bar Association

New York State Bar Association

New York Intellectual Property Law Association


Home | Site Map | Disclaimer | Privacy Statement | Employee Access

©2014 All content of this web site is the property and copyright of Fox Rothschild LLP and may not be reproduced in any format without prior express permission.
Contact marketing@foxrothschild.com for more information or to seek permission to reproduce content.

Attorney Advertising